Professor Preethi Kesavan, Director of Studies and Head, School of Advanced Technology and Digital Media at the London School of Business and Finance Singapore, analyses the Singaporean perspective on science and technology in advancing global healthcare.
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska explores the challenges and benefits of telemedicine following the COVID-19 pandemic.
Here, Open Access Government interview Dr Babita Agrawal, Professor in the Department of Surgery, University of Alberta to discuss the continued need for research into vaccines and immunotherapeutics.
Men’s health, both physical and mental is a topic that often gets brushed under the carpet. Here we explore what is being done to ensure men are receiving the healthcare they need this ‘Movember’.
Dr Chaand Nagpaul, Chair of the British Medical Association (BMA), said the UK Government "has taken its foot off the brake" - as COVID hospitalisations and infections continue to rise.
The 150-page Health and Social Committee report says the UK Government "ultimately failed" to establish a working Test and Trace system - which led to thousands of COVID deaths.
The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.
Investigating the current and future health priorities of Japan’s Ministry of Health, Labour and Welfare, including an increasing focus on cancer research.
The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.
